2722. Effects of Sex, Age, and Race on Immunogenicity of MenB-FHbp, a Bivalent Meningococcal B Vaccine: A Pooled Evaluation of Clinical Trial Data

BACKGROUND: MenB-FHbp (bivalent rLP2086), a meningococcal serogroup B vaccine, is approved in several countries for adolescents and young adults. MenB-FHbp elicited robust immune responses and had an acceptable safety profile during an extensive clinical development program. Because immune responses...

Descripción completa

Detalles Bibliográficos
Autores principales: Beeslaar, Johannes, Peyrani, Paula, Maguire, Jason, Eiden, Joseph, Palmer, Paul, Maansson, Roger, Crowther, Graham, Perez, John L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809720/
http://dx.doi.org/10.1093/ofid/ofz360.2399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809720/
http://dx.doi.org/10.1093/ofid/ofz360.2399

Ejemplares similares